Diabetes trends in Europe

被引:79
作者
Passa, P [1 ]
机构
[1] Hop St Louis, Dept Diabet, F-75475 Paris 10, France
关键词
epidemic expansion; health care costs; macrovascular complications; microvascular complications;
D O I
10.1002/dmrr.276
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estimates and projections suggest an epidemic expansion of diabetes incidence and prevalence in Europe. To evaluate trends in type 1 and type 2 diabetes in seven European countries (Finland, Denmark, the UK, Germany, France, Spain, and Italy), a variety of information is available, including population-based studies on small or large cohorts of subjects representative of the general population in a particular country, European co-operative studies, and sales figures for insulin and oral hypoglycemic agents that allow extrapolation of the number of pharmacologically treated diabetic patients. The incidence of type 1 diabetes in young people is increasing in most European countries, as is its prevalence in all age groups. Type 2 diabetes is the major contributor to the epidemic rise in diabetes. From 1995 to 1999, the prevalence of type 2 diabetes increased considerably, particularly in the UK, Germany, and France. Costs of ambulatory and in-hospital diabetic care (including antidiabetic, antihypertensive, and hypolipidemic agents) have increased even more rapidly than has the number of affected patients. Diabetes trends in Europe are alarming; health care professionals involved in diabetes care must be made aware of these detrimental trends, and health care delivery to patients with diabetes must be improved. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:S3 / S8
页数:6
相关论文
共 31 条
  • [1] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [2] 2-S
  • [3] Amos AF, 1997, DIABETIC MED, V14, pS7, DOI 10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO
  • [4] 2-I
  • [5] [Anonymous], 1995, Diabetes, V44, P1249
  • [6] [Anonymous], 1999, Diabetologia, V42, P647
  • [7] Incidence, prevalence, and mortality at diabetes in a large population -: A report from the Skaraborg Diabetes Registry
    Berger, B
    Stenström, G
    Sundkvist, G
    [J]. DIABETES CARE, 1999, 22 (05) : 773 - 778
  • [8] Detournay B, 1999, DIABETES METAB, V25, P356
  • [9] *EASD, 1999, EASD SAT S BRUSS 27
  • [10] PREVALENCE OF NIDDM AND IMPAIRED GLUCOSE-TOLERANCE IN ITALY - AN OGTT-BASED POPULATION STUDY
    GARANCINI, MP
    CALORI, G
    RUOTOLO, G
    MANARA, E
    IZZO, A
    EBBLI, E
    BOZZETTI, AM
    BOARI, L
    LAZZARI, P
    GALLUS, G
    [J]. DIABETOLOGIA, 1995, 38 (03) : 306 - 313